Wuhan YZY Biopharma Co (HKSE:02496) Price-to-Tangible-Book : 10.35 (As of Jun. 05, 2024)

View and export this data going back to 2023. Start your Free Trial

What is Wuhan YZY Biopharma Co Price-to-Tangible-Book?

As of today (2024-06-05), Wuhan YZY Biopharma Co's share price is HK$7.45. Wuhan YZY Biopharma Co's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was HK$0.72. Hence, Wuhan YZY Biopharma Co's Price to Tangible Book Ratio of today is 10.35.

The historical rank and industry rank for Wuhan YZY Biopharma Co's Price-to-Tangible-Book or its related term are showing as below:

HKSE:02496' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 10.35 Med: 12.36 Max: 12.36
Current: 10.35

During the past 3 years, Wuhan YZY Biopharma Co's highest Price to Tangible Book Ratio was 12.36. The lowest was 10.35. And the median was 12.36.

HKSE:02496's Price-to-Tangible-Book is ranked worse than
88.12% of 1221 companies
in the Biotechnology industry
Industry Median: 2.81 vs HKSE:02496: 10.35

A closely related ratio is called PB Ratio. As of today, Wuhan YZY Biopharma Co's share price is HK$7.45. Wuhan YZY Biopharma Co's Book Value per Sharefor the quarter that ended in Dec. 2023 was HK$0.72. Hence, Wuhan YZY Biopharma Co's P/B Ratio of today is 10.35.

Wuhan YZY Biopharma Co Price-to-Tangible-Book Historical Data

The historical data trend for Wuhan YZY Biopharma Co's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wuhan YZY Biopharma Co Price-to-Tangible-Book Chart

Wuhan YZY Biopharma Co Annual Data

Trend

Dec21

Dec22

Dec23

Price-to-Tangible-Book

12.36

Wuhan YZY Biopharma Co Semi-Annual Data
	Dec21	Dec22	Dec23
Price-to-Tangible-Book	-	-	12.36

Competitive Comparison of Wuhan YZY Biopharma Co's Price-to-Tangible-Book

For the Biotechnology subindustry, Wuhan YZY Biopharma Co's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Wuhan YZY Biopharma Co's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Wuhan YZY Biopharma Co's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Wuhan YZY Biopharma Co's Price-to-Tangible-Book falls into.

Wuhan YZY Biopharma Co Price-to-Tangible-Book Calculation

Wuhan YZY Biopharma Co's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	7.45	/	0.72
	=	10.35

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Wuhan YZY Biopharma Co Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Wuhan YZY Biopharma Co's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Wuhan YZY Biopharma Co (HKSE:02496) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Wuhan YZY Biopharma Co Ltd (HKSE:02496) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 666 Gaoxin Road, East Lake High Tech, Development Zone, Hubei Province, Wuhan, CHN

Website

https://en.yzybio.com/

Wuhan YZY Biopharma Co Ltd is a biotechnology company specifically involved in developing bispecific antibody based therapies to treat cancer or cancer-associated complications, cancer and age-related ophthalmologic diseases to address medical demands in oncology and aging-related ophthalmologic disease areas, The Company has been operating in one reportable segment, being the discovering, developing and commercializing new class of innovative medicines in respect to anti-tumor bispecific antibody.

Executives

Dragon Merit Holdings Limited	2201 Interest of corporation controlled by you
Robust Sun Holdings Limited	2201 Interest of corporation controlled by you
Cspc Pharmaceutical Group Limited	2201 Interest of corporation controlled by you
Shi Yao Ji Tuan En Bi Pu Yao Ye You Xian Gong Si	2101 Beneficial owner
He Bei Yi Er Qi Ye Guan Li Zi Xun You Xian Gong Si	2201 Interest of corporation controlled by you
Ning Bo Mei Shan Bao Shui Gang Qu Guang Rui Hong Xiang Gu Quan Tou Zi He Huo Qi Ye You Xian He Huo	2101 Beneficial owner
Guo Xin Si Chuang Tou Zi Ji Jin Guan Li Bei Jing You Xian Gong Si	2201 Interest of corporation controlled by you
Guo Hong Wei
Nan Jing Cai Zhi Er Hao Qi Ye Guan Li He Huo Qi Ye You Xian He Huo	2101 Beneficial owner
Nan Ning Hui You Xing Yao Gu Quan Tou Zi Ji Jin He Huo Qi Ye You Xian He Huo
Nan Ning Yao You Shang Wu Zi Xun He Huo Qi Ye You Xian He Huo
Wen Zhi Cheng
Tong De Qian Yuan Bei Jing Tou Zi Guan Li You Xian Gong Si
Wang Hongjie	2201 Interest of corporation controlled by you
Wu Shangzhi	2201 Interest of corporation controlled by you

Wuhan YZY Biopharma Co (HKSE:02496) Headlines

No Headlines